arXiv:2606. 19899v1 Announce Type: cross Abstract: This paper addresses a rapidly emerging policy challenge: how to generate and interpret credible evidence about the biological capabilities and risks of AI scientists, or agentic AI systems capable of autonomously or collaboratively performing multi-step scientific tasks.
By Patricia Paskov, Jeffrey Lee, Kyle Brady, Alyssa Worland
arXiv:2603. 11001v3 Announce Type: replace-cross Abstract: Human uplift studies, or studies that measure the effects of AI access on human performance via randomized controlled trials (RCT) or similar methodologies, increasingly inform frontier AI governance and deployment decisions.
By Patricia Paskov, Kevin Wei, Shen Zhou Hong, Dan Bateyko, Xavier Roberts-Gaal, Carson Ezell, Gailius Praninskas, Valerie Chen, Umang Bhatt, Ella Guest
arXiv:2601. 09753v2 Announce Type: replace-cross Abstract: AI science evaluation tools aim to assess research credibility.
By Carole J. Lee
arXiv:2511. 19735v2 Announce Type: replace-cross Abstract: Randomized controlled trials (RCTs)have been the cornerstone of clinical evidence; however, their cost, duration, and restrictive eligibility criteria limit power and external validity.
By Shu Yang, Margaret Gamalo, Haoda Fu
arXiv:2605. 08827v2 Announce Type: replace Abstract: The safety of mental health AI is often judged at the wrong temporal scale.
By Srimonti Dutta, Ratna Kandala
arXiv:2606. 02458v1 Announce Type: new Abstract: Organizations routinely run experiments for A/B testing, yet the data generated from one experiment is underutilized to inform subsequent intervention design.
By Junjie Luo, Ritu Agarwal, Gordon Gao